Drag a card by its title · ⚙ to size, swap or remove

The company

Scholar Rock Holding Corporation

SRRK · Nasdaq

Health CareBiotechnologyNot moving yet

SRRK stood above a rising 150-day average in 40 of the last 52 weekly readings, and has been out of that trend for the last 5 weeks. It is 19.0% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 5
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $32.7M
Officials’ trades on record: 0
Institutions holding: 290 (+32)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 40 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months26

Buyers · sellers0 · 13

Who	Did	Shares	Traded
Katie PengDirector	sold	2,988at $53.56	1 Jul 2026filed 6 Jul 2026
Katie PengDirector	sold	2,437at $54.25	1 Jul 2026filed 6 Jul 2026
Katie PengDirector	sold	21at $54.96	1 Jul 2026filed 6 Jul 2026
Joshua ReedDirector	sold	2,105at $53.50	1 Jul 2026filed 6 Jul 2026
Joshua ReedDirector	sold	948at $54.28	1 Jul 2026filed 6 Jul 2026
Kristina BurowDirector	sold	2,105at $53.49	1 Jul 2026filed 6 Jul 2026
Kristina BurowDirector	sold	948at $54.28	1 Jul 2026filed 6 Jul 2026
Michael GilmanDirector	sold	1,346at $53.54	1 Jul 2026filed 6 Jul 2026
Michael GilmanDirector	sold	1,155at $54.23	1 Jul 2026filed 6 Jul 2026
Michael GilmanDirector	sold	43at $54.81	1 Jul 2026filed 6 Jul 2026
Jeffrey S. FlierDirector	sold	1,568at $53.53	1 Jul 2026filed 6 Jul 2026
Jeffrey S. FlierDirector	sold	1,470at $54.24	1 Jul 2026filed 6 Jul 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders290+32 on the quarter

New · exited58 · 25

Reported value$7.3B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
FMR LLCadded · filed 13 Aug 2026	17,995,241$989.7M	+752,089+4.4%
Siren, L.L.C.reduced · filed 13 Aug 2026	9,575,013$526.6M	-1,250,000−11.5%
BlackRock, Inc.added · filed 7 Aug 2026	9,494,084$522.2M	+2,024,791+27.1%
SAMSARA BIOCAPITAL, LLCunchanged · filed 14 Aug 2026	6,897,652$379.4M	00.0%
WELLINGTON MANAGEMENT GROUP LLPadded · filed 14 Aug 2026	6,727,085$370.0M	+9,430+0.1%
Orbis Allan Gray Ltdadded · filed 14 Aug 2026	5,933,533$326.3M	+1,753,550+42.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	4,767,880$262.2M	+876,533+22.5%
STATE STREET CORPadded · filed 7 Aug 2026	4,728,681$260.1M	+697,364+17.3%
Redmile Group, LLCreduced · filed 14 Aug 2026	4,311,092$237.1M	-4,755,529−52.5%
NORGES BANKnew · filed 12 Aug 2026	2,769,910$152.3M	+2,769,910